Sudeep Pharma Ltd. (SUDEEPPHRM) 52 Week High Streak Extends to Fourth Session

Updated: 4 Sept 2026 • 9:22 am

Posted by:

Sudeep Pharma Ltd. (SUDEEPPHRM) 52 Week High Streak Extends to Fourth Session

Sudeep Pharma Ltd. (SUDEEPPHRM) share price reached a fresh 52-week high of Rs 1,315 today and later stood at Rs 1,311.6, up 1.25% from the previous close. Market cap was Rs 13,945.77 crore.

Sudeep Pharma Ltd. has now set a fresh 52-week high for its fourth consecutive session, with the streak advancing 8.37% across that run. The latest peak stood at Rs 1,315, while the stock last traded at Rs 1,311.6. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.

As of 04 September 2026 at 9:18 AM IST, the stock was above its previous close of Rs 1,295.35 after opening at Rs 1,305.5 and touching a low of Rs 1,303.4. Turnover stood at Rs 0.02 crore and market capitalisation at Rs 13,945.77 crore. For readers, the key point is not just the day’s move; it is the fact that Sudeep Pharma Ltd. has kept resetting its 52-week high across multiple sessions.

Table of Contents

Sudeep Pharma Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 1,311.6
Previous Close	Rs 1,295.35
Today's Move	+Rs 16.25 (+1.25%)
Open	Rs 1,305.5
High	Rs 1,315
Low	Rs 1,303.4
Turnover	Rs 0.02 crore
Market Capitalisation	Rs 13,945.77 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 1,311.6 versus the previous close of Rs 1,295.35, a rise of 1.25%. The stock opened at Rs 1,305.5, reached a high of Rs 1,315 and touched a low of Rs 1,303.4.

Sudeep Pharma Ltd. share price today reflected a steady start around the higher band of the day’s range, with the stock last trading at Rs 1,311.6, up Rs 16.25 or 1.25% from the previous close. The day’s range was narrow, with a low of Rs 1,303.4 and a high of Rs 1,315, which also marked the fresh 52-week high in the current streak.

The opening price of Rs 1,305.5 placed the stock close to the upper part of the range early in the session. That matters for the share price update because it shows the stock remained near the day’s top price rather than drifting materially away from it. Turnover was Rs 0.02 crore, while market capitalisation stood at Rs 13,945.77 crore, keeping Sudeep Pharma Ltd. in the same broad market-cap band as several listed pharmaceutical peers.

Sudeep Pharma Ltd. 52 Week High Streak: Consecutive High Analysis

Sudeep Pharma Ltd. 52 Week High Streak now spans four straight sessions, and the latest number is the fresh 52-week peak of Rs 1,315. Across the streak, the stock has moved up 8.37%, which is the most relevant figure for readers tracking whether the repeated highs are meaningful beyond a single-day breakout. The first breakout in this run happened on 01 September 2026, and the stock has extended that pattern on each subsequent trading day.

The main comparison point for this phase is the previous 52-week high, which the stock has now moved beyond by the latest peak of Rs 1,315. Because this is a repeated-high pattern, the focus shifts from a one-session event to a sequence of higher reference points. The latest Univest data confirms the pattern; it does not identify a company-specific trigger for why the stock has kept registering new one-year highs.

What the Repeated 52-Week Highs Show

Repeated 52-week highs usually tell readers that the stock is being repriced at progressively higher levels over multiple sessions, but this article only draws what the numbers support. In Sudeep Pharma Ltd.’s case, the key factual signal is the four-session streak, the 8.37% cumulative rise, and the fact that the latest high is Rs 1,315. That is enough to say the move has extended beyond a one-day event.

The repeated-high pattern also helps separate a routine market update from a broader stock price update. A single fresh high can be an isolated headline; back-to-back highs, and then a fourth consecutive session at a new one-year high, show persistence in the price pattern. At the same time, the data set does not confirm a company-specific development, so the correct reading is that the pattern is real while the reason remains unconfirmed from the numbers alone.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 13,945.77 crore
P/E Ratio	80.11x
P/B Ratio	15.84x
ROE	25.37%
ROCE	28.5%
EPS	Rs 16.17
Book Value Per Share	Rs 81.8
Dividend Yield	0.12%

Sudeep Pharma Ltd. (SUDEEPPHRM) fundamental metrics show P/E 80.11x, P/B 15.84x, ROE 25.37%, ROCE 28.5%. These figures provide context only and are not a buy or sell signal.

Sudeep Pharma Ltd. has a market capitalisation of Rs 13945.77 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 80.11x, P/B at 15.84x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.37% and ROCE of 28.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 16.17, book value per share of Rs 81.8, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.28x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	80.11x
Benchmark Median P/E	32.28x
Benchmark Average P/E	48.64x
Benchmark P/E Range	3.32x to 645.91x
Company P/B Ratio	15.84x
Benchmark Median P/B	2.85x
Company ROE	25.37%
Benchmark Median ROE	11.78%
Company ROCE	28.5%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 13,945.77 crore
Benchmark Median Market Cap	Rs 723.58 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 80.11x, which is above the benchmark median of 32.28x, a difference of +148.17%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 25.37%, which is above the benchmark median of 11.78%, a difference of +115.37%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 28.5%, which is above the benchmark median of 13.65%, a difference of +108.79%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Jubilant Pharmova Ltd.	JUBLPHARMA	14,423.7	41	2.02	5.97	8.69
Marksans Pharma Ltd.	MARKSANS	15,067.69	29.1	4.73	15.31	21.1
Concord Biotech Ltd.	CONCORDBIO	15,090.36	55.03	7.31	13.54	18.04
Natco Pharma Ltd.	NATCOPHARM	15,100.75	13.12	1.61	27.98	32.85
CORONA Remedies Ltd.	CORONA	12,544.85	65.28	16.1	27.36	31.74

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 80.11x compared with the displayed peer median of 41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.37% compares with a peer median of 15.31% across the companies shown in the table. ROCE stood at 28.5% versus the displayed peer median of 21.1%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 13,945.77 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma Ltd.

Sudeep Pharma Ltd. has set a fresh 52-week high for a fourth straight session.
The cumulative move across the streak is 8.37%, which is the main event-level measure.
The latest high of Rs 1,315 is above the previous reference high used in the streak.
The stock is trading at a P/E of 80.11 and a P/B of 15.84.
ROE of 25.37% and ROCE of 28.5% keep the fundamental snapshot in focus.

About Sudeep Pharma Ltd.

Sudeep Pharma Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. The company’s latest market capitalisation stands at Rs 13,945.77 crore, placing it among the more closely watched names in the listed pharmaceutical universe covered here. For readers tracking Sudeep Pharma Ltd. share price today, the current phase is notable because the stock is not just near its 52-week high; it has kept making new one-year highs across multiple sessions.

The latest financial snapshot shows EPS of Rs 16.17, book value of Rs 81.8 and dividend yield of 0.12%, alongside higher-than-median return ratios. Those figures help frame the stock news context, but the current article is centered on the repeated 52-week high pattern and what that says about the ongoing share price update.

Track Sudeep Pharma Ltd. on Univest

Follow Sudeep Pharma Ltd. on Univest for the latest stock performance, market update and fresh 52-week high tracking. The stock page brings together the share price, financial ratios and sector context in one place, making it easier to monitor whether the consecutive high pattern continues in the next session.

For the most useful read, revisit the company page when new market data prints during the day. That helps you compare the live stock price with the current 52-week high and the broader sector backdrop without having to search across multiple sources.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why is Sudeep Pharma Ltd. still hitting 52-week highs?

Ans. According to the latest Univest figures, Sudeep Pharma Ltd. has set fresh one-year highs for four straight sessions. The numbers confirm the pattern, but they do not identify a company-specific catalyst for the repeated move.

How many consecutive sessions has Sudeep Pharma Ltd. made a new 52-week high?

Ans. The stock has now recorded a fresh 52-week high for its fourth consecutive session. That makes it a multi-session streak rather than a one-day breakout. The stock moved 1.25% so far today.

What is the cumulative move across the Sudeep Pharma Ltd. 52 Week High Streak?

Ans. The cumulative streak change is 8.37%. That is the best single measure for understanding how much the stock has moved across the full run of consecutive highs.

What is the latest 52-week high for Sudeep Pharma Ltd.?

Ans. The latest 52-week high is Rs 1,315. The stock last traded at Rs 1,311.6, which kept it close to that peak during the morning session. The stock moved 1.25% so far today.

How does Sudeep Pharma Ltd. compare with its previous high?

Ans. The current peak is above the prior reference high used in the streak. The repeated-high pattern shows that the stock has continued to reset its one-year peak over several sessions.

Is Sudeep Pharma Ltd. expensive on valuation?

Ans. Sudeep Pharma Ltd. trades at a P/E of 80.11 and a P/B of 15.84, both well above the industry medians in the latest snapshot. That places valuation firmly in focus for readers following the stock.

How do Sudeep Pharma Ltd. ROE and ROCE compare with the industry?

Ans. The company’s ROE of 25.37% and ROCE of 28.5% are higher than the sector medians shown in the snapshot. That makes the return-ratio profile stronger than the wider industry reference set.

What should investors monitor next in Sudeep Pharma Ltd.?

Ans. Investors can watch whether the stock continues to post fresh 52-week highs, how the share price trades around the latest peak, and whether future company updates or market data add context to the current streak.